BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zandanell S, Strasser M, Feldman A, Strebinger G, Aigner G, Niederseer D, Laimer M, Mussnig B, Paulweber B, Datz C, Aigner E. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up. Postgrad Med 2021;133:291-8. [PMID: 33538618 DOI: 10.1080/00325481.2021.1885945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis. Dig Dis Sci 2021. [PMID: 34181166 DOI: 10.1007/s10620-021-07122-y] [Reference Citation Analysis]
2 Colapietro F, Lleo A, Generali E. Antimitochondrial Antibodies: from Bench to Bedside. Clin Rev Allergy Immunol 2021. [PMID: 34586589 DOI: 10.1007/s12016-021-08904-y] [Reference Citation Analysis]